Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound.
Drug patent litigation for ASENAPINE MALEATE.
Two suppliers are listed for this compound. There is one tentative approval for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
